0001415889-21-004885.txt : 20211015
0001415889-21-004885.hdr.sgml : 20211015
20211015184440
ACCESSION NUMBER: 0001415889-21-004885
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211014
FILED AS OF DATE: 20211015
DATE AS OF CHANGE: 20211015
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bohen Sean
CENTRAL INDEX KEY: 0001831218
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39712
FILM NUMBER: 211327005
MAIL ADDRESS:
STREET 1: C/O OLEMA PHARMACEUTICALS, INC.
STREET 2: 512 2ND STREET, 4TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Olema Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001750284
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 300409740
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 512 2ND STREET, 4TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
BUSINESS PHONE: (415) 651-3316
MAIL ADDRESS:
STREET 1: 512 2ND STREET, 4TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
4
1
form4-10152021_031031.xml
X0306
4
2021-10-14
0001750284
Olema Pharmaceuticals, Inc.
OLMA
0001831218
Bohen Sean
C/O OLEMA PHARMACEUTICALS, INC.
512 2ND STREET, 4TH FLOOR
SAN FRANCISCO
CA
94107
true
true
false
false
PRESIDENT AND CEO
Common Stock
2021-10-14
4
M
0
5000
4.824
A
57514
D
Common Stock
2021-10-14
4
S
0
4649
30.42
D
52865
D
Common Stock
2021-10-14
4
S
0
351
31.17
D
52514
D
Stock Option (Right to Buy)
4.824
2021-10-14
4
M
0
5000
0
D
2030-11-18
Common Stock
5000
966316
D
The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
The weighted average sale price for the transaction reported was $30.42, and the range of prices were between $30.00 and $30.99. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
The weighted average sale price for the transaction reported was $31.17, and the range of prices were between $31.00 and $31.28. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
(A) 256,992 of the shares subject to the option vest on September 1, 2021, (B) 2,411 of the shares subject to the option vest on January 1, 2022 and 2,410 of the shares subject to the option vest on January 1 of each of 2023 and 2024 and (C) 23,143 of the shares subject to the option vest on the 1st day of each month (other than on September 1, 2021 and each of January 1, 2022, 2023 and 2024) following September 1, 2021, plus an additional 23 shares on September 1, 2024. Subject to, in each case of (A) - (C) above, the Reporting Person's continuous service on each applicable vesting date. The stock option is early exercisable.
/s/ John B. Moriarty, Jr., Attorney-in-Fact
2021-10-15